Searchable abstracts of presentations at key conferences in endocrinology

ea0011p128 | Clinical case reports | ECE2006

Time course of neuroendocrine dysfunction after aneurysmal subarachnoid hemorrhage – need for reassessment even years after the hemorrhage?

Reineke A , Poll E , Levasseur S , Yagmur E , Gilsbach JM , Kreitschmann-Andermahr I

In recent years there has been increasing evidence for neuroendocrine dysfunction as a sequel of aneurysmal subarachnoid hemorrhage (SAH). One investigation has assessed pituitary function in SAH-survivors in a longitudinal design 3 and 12 months after the hemorrhage, but nothing is known about the dynamics of the hypothalamo-pituitary axis in the years following the bleeding. We present the data of 5 patients who had sustained aneurysmal SAH and had undergone their first endo...

ea0011p613 | Neuroendocrinology and behaviour | ECE2006

Quality of life (QoL) and psychiatric sequelae following aneurysmal subarachnoid hemorrhage (SAH): Does neuroendocrine dysfunction play a role?

Kreitschmann-Andermahr I , Poll E , Saller B , Reineke A , Gilsbach JM , Hütter BO

QoL is an important outcome criterion in clinical research and is used to monitor treatment effects. Patients who have sustained SAH oftentimes have impaired QoL as do patients with untreated hypopituitarism. Considering the high degree of partial hypopituitarism in SAH survivors, we sought to elucidate the impact of neuroendocrine dysfunction on QoL and the prevalence of psychiatric sequelae in these patients.QoL, depression and symptoms of posttraumati...